At close: December 11 at 4:00:02 PM EST
Pre-Market: 4:19:50 AM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 9 | 14 | 13 |
Avg. Estimate | 0.73 | -0.11 | 1.33 | 1.95 |
Low Estimate | 0.6 | -0.33 | 1.2 | 1.5 |
High Estimate | 0.81 | 0.33 | 1.4 | 2.59 |
Year Ago EPS | 0.49 | -0.34 | -0.72 | 1.33 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 16 | 11 | 17 | 17 |
Avg. Estimate | 232.9M | 199.2M | 795.97M | 951.05M |
Low Estimate | 229.9M | 191.28M | 793M | 934.8M |
High Estimate | 235.2M | 206.43M | 798.3M | 972M |
Year Ago Sales | 192.51M | 164.01M | 624.8M | 795.97M |
Sales Growth (year/est) | 20.98% | 21.46% | 27.40% | 19.48% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -0.09 | -0.67 | -0.11 | 0.08 |
EPS Actual | 0.49 | -0.34 | 0.32 | 0.6 |
Difference | 0.58 | 0.33 | 0.43 | 0.52 |
Surprise % | 628.59% | 49.17% | 382.89% | 683.60% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.73 | -0.11 | 1.33 | 1.95 |
7 Days Ago | 0.73 | -0.07 | 1.33 | 1.95 |
30 Days Ago | 0.72 | -0.07 | 1.33 | 1.92 |
60 Days Ago | 0.66 | -0.14 | 0.74 | 1.25 |
90 Days Ago | 0.65 | -0.13 | 0.73 | 1.26 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 6 | 13 | 1 |
Up Last 30 Days | 10 | 5 | 13 | 13 |
Down Last 7 Days | -- | 1 | -- | -- |
Down Last 30 Days | 3 | 2 | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
INSP | 48.20% | 66.75% | 284.10% | 46.87% |
S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
Upgrade | B of A Securities: Neutral to Buy | 11/20/2024 |
Reiterates | RBC Capital: Outperform to Outperform | 11/5/2024 |
Reiterates | Piper Sandler: Overweight to Overweight | 11/5/2024 |
Reiterates | Stifel: Hold to Hold | 11/5/2024 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 11/5/2024 |
Maintains | Baird: Outperform to Outperform | 11/5/2024 |
Related Tickers
IRTC iRhythm Technologies, Inc.
89.93
+3.49%
CNMD CONMED Corporation
73.32
-1.90%
PEN Penumbra, Inc.
253.66
+4.70%
NARI Inari Medical, Inc.
58.21
+5.74%
NVRO Nevro Corp.
4.3100
-0.69%
GKOS Glaukos Corporation
142.89
+4.77%
PODD Insulet Corporation
273.47
-0.48%
MASI Masimo Corporation
174.38
-0.15%
BFLY Butterfly Network, Inc.
3.6100
-1.63%
NSPR InspireMD, Inc.
3.1700
+0.96%